In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE Drug Master File in Korea (CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE. The MFDS reviews the CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE KDMF as part of the drug registration process and uses the information provided in the CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE KDMF to evaluate the safety and efficacy of the drug.
After submitting a CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE suppliers with KDMF on PharmaCompass.